COSRX 6 Peptide Mini vs The Ordinary Copper Peptides
A comparison of selected label facts, with different sizes and disclosure limits. No clinical winner is established.

The 6 Peptide Skin Booster Serum Mini
50 mL · Facial serum
Price not verifiedNo verified price for this size.

Multi-Peptide + Copper Peptides 1% Serum
30 mL · Facial serum
$32.00USD · Recorded 2026-10-18
What matters in 30 seconds.
The key findings, without the chemistry lesson.
What is documented?
This COSRX record is the 50 mL mini; The Ordinary record is 30 mL. Their selected peptide names and disclosures differ.[1][2]
Manufacturer labels
See ingredient differencesWhat does it mean for your purchase?
COSRX has no verified price in this record, so a fair unit-cost comparison remains unavailable. Do not substitute a 150 mL offer.[1][2]
Recorded prices · not a performance ranking
Understand the priceWhat has not been demonstrated?
This label comparison does not establish which finished serum works better or is safer. Individual tolerance and additional benefit cannot be predicted from the selected names.
Editorial interpretation of label information
Check the evidenceBefore you choose: label facts do not establish which finished formula is safer or more effective. If you have a confirmed ingredient allergy, check the full label before buying.
Understand the evidenceIngredients, price and the gaps.
Compare selected label facts. Tap an ingredient to understand its name.
Compare recorded facts side by side. Missing information is not a negative rating.
| Compare the detailsTwo products. The same questions. | ||
|---|---|---|
| Product basics | ||
| Presentation | 50 mL | 30 mL |
| Format | First-step cosmetic serum | Water-based serum |
| How the brand says to use it | The manufacturer describes use after cleansing, as a first step. Follow current package directions.Manufacturer directions, not a personalized routine. | Directions not recorded. Read the manufacturer's current instructions.Manufacturer directions, not a personalized routine. |
| Price & value | ||
| Recorded price | Price not verifiedNo verified price for this size. | $32.00 USDPrice recorded Excludes tax and shipping. |
| Price per mL | Price not verifiedRequires a verified price for this size. | $1.07 / mL |
| What it contains and what it means | ||
| Peptides, explained Peptides are small chains of the building blocks used in proteins. Their names identify ingredients, not quality scores. Open an explanation to learn what each one means. |
|
|
| How much of each ingredient? A formula is the whole mix. A blend percentage does not tell us the amount of every ingredient. | Six describes the named peptide blend, not a percentage or an efficacy score.Manufacturer disclosure; not independently measured.Individual amounts not verified | The product name states 1% copper peptides. Amounts of the other selected peptides are not recorded.Manufacturer disclosure; not independently measured.Individual amounts not verified |
| Sources & limits | ||
| What we still cannot know | Not established
| Not established
|
| Label source | COSRX manufacturer label Label checked Label checked; not a clinical review. | The Ordinary manufacturer label Label checked Label checked; not a clinical review. |
Prices are dated USD observations. Ingredient selections are incomplete; matching names do not establish equivalent formulas or results.
What do the label differences mean?Exact names, disclosures and cost limits
Different presentations
Match the exact size before comparing an offer. This COSRX record is the 50 mL mini.[1][2]
Different disclosures
The Ordinary names 1% copper peptides. COSRX’s six-peptide name counts components; it is not a comparable concentration.[1][2]
Documented differences
The recorded COSRX mini is 50 mL; The Ordinary record is 30 mL. Both selected lists include Copper Tripeptide-1 and Acetyl Hexapeptide-8.[1][2]
Use this comparison for your decision
Confirm the bottle
Use the exact mini presentation when reviewing this pair.[1]
Read the full label
Selected lists omit non-peptide ingredients; they are not full-formula equivalence checks.[1][2]
What the sources tell us.
What do the source labels mean?
Human studies describe what happened in their participants and tested preparation. Laboratory studies examine a model, not clinical results in shoppers. Case reports describe individual events, not how often they occur.
Safety assessments review specified uses and concentrations. Manufacturer labels identify recorded product facts. Neither is a guarantee of results or individual tolerance. Source type is not a quality score.
What the labels document
Source type: Manufacturer label
This COSRX record is the 50 mL mini; The Ordinary record is 30 mL. Their selected peptide names and disclosures differ.[1][2]
Amounts: disclosure is not measurement
Source type: Manufacturer label
Headline disclosures do not give verified individual amounts for every selected peptide.[1][2]
Read the evidence and what it means
Source type: Manufacturer label
COSRX: Six describes the named peptide blend, not a percentage or an efficacy score.[1]
Source type: Manufacturer label
The Ordinary: The product name states 1% copper peptides. Amounts of the other selected peptides are not recorded.[2]
What these sources cannot establish
Source type: Human ingredient study · Safety assessment
Recorded labels do not establish a clinical winner or years of safety for these complete formulas.[3][4]
Read the evidence and what it means
Source type: Human ingredient study · Safety assessment
The Argireline trial concerns a preparation, not either retail product in this pair. CIR addresses specified cosmetic safety uses, not a comparative benefit trial.[3][4]
Different study preparation. Not a test of either compared serum.
Editorial interpretation
This is a comparison of selected label information, not a complete clinical efficacy or safety review. Missing product-level evidence here is not evidence that either product is harmful or ineffective.
Cost and the exact presentation
Editorial interpretation
COSRX has no verified price in this record, so a fair unit-cost comparison remains unavailable. Do not substitute a 150 mL offer.
Read the evidence and what it means
Editorial interpretation
Selected names, no verified COSRX availability or comparable cost, and no finished-product head-to-head clinical evaluation. Scientific review pending.
What is recorded on the labels?
Source type: Manufacturer label
The paired manufacturer sources document the recorded product names and selected ingredients. These lists are incomplete, formulas may change, and manufacturer information is not independent clinical corroboration.[1][2]
Manufacturer links establish ingredient presence only. Scientific references support the research statements above. Formulas can change; check your purchased packaging.
Questions about these products
Do shared names mean equal results?
Is there a fair cost comparison?
Not yet. No COSRX price is published here because the availability information requires clarification.[1]
Check the original sources
Research and safety assessments are separate from manufacturer labels.
How this comparison was preparedScope, review status and limitations
What we cannot tell from the label
Selected names, no verified COSRX availability or comparable cost, and no finished-product head-to-head clinical evaluation. Scientific review pending.
Read our methodologyWhere to buy
Check the exact size, current price and shipping at the manufacturer.
No affiliate partnerships are active. Manufacturer links are ordinary links; we do not earn commissions from them. Recorded prices exclude tax and shipping and may have changed.
References
- Manufacturer labelCOSRX The 6 Peptide Skin Booster Serum Mini (50 mL): official label
Evidence and limitations for reference 1
- What this supports here
- Exact mini label, selected names and presentation.
- What it cannot establish
- Commercial source; not a clinical trial. Page says unavailable while public feed marks the variant available, so price and availability are not published. Review widgets include unrelated sunscreen text and were not used.
- Commercial context and disclosures
- Published by the product seller.
- What we inspected
- Public source text inspected; underlying clinical dossiers not independently reanalysed.
- Manufacturer labelMulti-Peptide + Copper Peptides US product label
Evidence and limitations for reference 2
- What this supports here
- Supports the selected peptide names, product name and 30 mL presentation.
- What it cannot establish
- Manufacturer claims and label checks do not establish clinical superiority over NIOD. Price observation dates are separate from this reference check.
- Commercial context and disclosures
- NIOD and The Ordinary are both DECIEM brands; these are commercial sources, not independent corroboration.
- What we inspected
- Public US product page
- Human ingredient study
Wang Y, Wang M, Xiao S, Pan P, Li P, Huo J. 2013. American Journal of Clinical Dermatology, 14(2), 147–153.
The Anti-Wrinkle Efficacy of Argireline, a Synthetic Hexapeptide, in Chinese Subjects: A Randomized, Placebo-Controlled StudyDOI: 10.1007/s40257-013-0009-9
Evidence and limitations for reference 3
- What was studied
- Randomized, placebo-controlled; 60 Chinese participants, 3:1 allocation, four weeks.
- What was reported
- The abstract reports improved eye-area wrinkle measures with Argireline relative to placebo.
- What this supports here
- An example of ingredient research with a defined population and duration, rather than a test of either compared copper serum.
- What it cannot establish
- Four weeks in one population. Neither CAIS3 nor The Ordinary’s copper serum is the tested product identified in the abstract. No product winner or long-term safety conclusion follows.
- Commercial context and disclosures
- The publisher reports no funding and no declared conflicts. These are author declarations, not an independent audit.
- What we inspected
- Publisher abstract and acknowledgments inspected; full methods behind subscription were not reviewed.
- Publication status check
- No correction or retraction notice was seen on the inspected publisher page. This is not a comprehensive integrity clearance.
- Expert safety assessment
Johnson W Jr, Bergfeld WF, Belsito DV, et al. 2018. International Journal of Toxicology.
Safety Assessment of Tripeptide-1, Hexapeptide-12, Their Metal Salts and Fatty Acyl Derivatives, and Palmitoyl Tetrapeptide-7 as Used in CosmeticsEvidence and limitations for reference 4
- What was studied
- Expert assessment of specified cosmetic peptide ingredients; underlying final report released June 30, 2014.
- What was reported
- The panel’s favorable conclusion is conditional on the reviewed uses, concentrations and peptide identities.
- What this supports here
- Provides a scoped safe-use conclusion for specified peptide identities, practices and concentrations.
- What it cannot establish
- Does not test these finished products or establish their safety over years. NIOD’s exact label name is not silently equated with a different name in the report.
- Commercial context and disclosures
- CIR is funded by the Personal Care Products Council and describes its panel/review process as independent. Industry-submitted data are included; this is not a government approval.
- Source organization and funding context
- What we inspected
- 2018 publisher full-text abstract, ingredient scope and introduction revisited; prior 2014 final-report discussion check retained. Not an independent toxicology reanalysis.